Company: TeamPioneering in the field of Fibrobody-Drug Conjugates
Pioneering in the field of Fibrobody-Drug Conjugates
Our multidisciplinary team comprises chemists, biologists, biotechnicians and drug development specialists
The team
Targeted drug delivery sounds like a simple solution to diseases that are difficult to treat - But the development of targeted drugs is far from simple.
Our team of expert scientists covers all aspects of targeted drug delivery - from early discovery to production, and from preclinical evaluation to clinical studies. That's why we employ talented organic chemists, molecular biologists, biochemists, biotechnologists, and drug development specialists.
Management Board
Bart Nijmeijer
Chief Executive Officer
Prof. Guus van Dongen
Chief Scientific Officer
Samuel Oudkerk
Chief Financial Officer